Description: Moolec Science is a science-based ingredient company focused on producing animal proteins in plants through Molecular Farming, a disruptive technology in the alternative protein landscape. Its purpose is to upgrade the taste, nutrition, and affordability of alternative protein products while building a more sustainable and equitable food system. The company’s technological approach aims to have the cost structure of plant-based solutions with the organoleptic properties and functionality of animal-based ones. Moolec Science’s technology has been under development for more than a decade and is known for pioneering the production of a bovine protein in a crop for the food industry. The company’s product portfolio and pipeline leverages the agronomic efficiency of broadly used target crops, like soybeans and peas and Moolec Science has a growing international patent portfolio (22, both granted and pending) for its Molecular Farming technology. The company is run by a diverse team of Ph.Ds and Food Insiders, and operates in the United States, Europe, and South America.
Home Page: moolecscience.com
MLEC Technical Analysis
17, Boulevard F.W. Raiffeisen
Luxembourg,
2411
Luxembourg
Phone:
352 26 49 65 65
Officers
| Name | Title |
|---|---|
| Mr. Gaston Paladini M.B.A. | Co-Founder, CEO & Director |
| Mr. Henk Hoogenkamp Ph.D. | Co-Founder & Chief Product Officer |
| Mr. Martin Salinas Ph.D. | Chief of Technology & Co-Founder |
| Mr. Jose Lopez Lecube M.B.A. | CFO & Director |
| Dr. Amit Dhingra Ph.D. | Chief Science Officer |
| Florencia Bottero | Corporate Counsel & Secretary of the Board |
| Ms. Catalina Jones B.A. | Chief of Staff & Sustainability |
Exchange: NASDAQ
Country: US : United States of America
Currency: US Dollar ($)
| GIC Sector: | Health Care |
|---|---|
| GIC Group: | Pharmaceuticals, Biotechnology & Life Sciences |
| GIC Industry: | Biotechnology |
| GIC Sub-Industry: | Biotechnology |
| Forward PE: | 0 |
|---|---|
| Trailing PE: | 0 |
| Price-to-Book MRQ: | 4.7261 |
| Price-to-Sales TTM: | 6.2718 |
| IPO Date: | 2023-01-03 |
| Fiscal Year End: | June |
| Full Time Employees: | 52 |